Creating Capital Market Tools
for the Healthcare Economy


Poliwogg applies metrics specific to biotechnology and pharmaceuticals that are not applicable to other sectors or industries, resulting in highly idiosyncratic performance characteristics. Indexes are comprised of companies that are principally engaged in the US health care sector, with a strong emphasis on the dynamic small/mid-capitalization biotechnology segment.

Learn More

We Believe

  • Current investment products do not reflect the opportunity nor complexity in the healthcare sector
  • There should be capital market tools in healthcare as there are in other sectors
  • Healthcare should be a financial asset, not just a cost
  • The advent of big data enables exciting new financial products
  • The pace of medical innovation is accelerating

Poliwogg In the News